EUVIMEDEUVIMED entdecken
Crossref

Nuclear Factor Kappa‐B Inducing Kinase‐ and Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Binding Protein Promotes Pathological Cardiac Hypertrophy by Regulating Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Mediated Nuclear Factor Kappa‐B Activation

Zheng Xie, Yingjie Zuo iD, Mengyao Wang iD, Xin Zhang iD, Lirong Zhang, Zixuan Liu, Bilong Zhang, Zhaohai Su, Saichao Yang, Hailong Yang iD, Jianqing Zhang, Zhonghan Ni iD und 2 weitere

Journal of the American Heart Association · 03.11.2026 · 15 (21)

DOI: 10.1161/jaha.125.046637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.11.2026. Verfasst von Zheng Xie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Guangdong Provincial People's Hospital Ganzhou Hospital Ganzhou Municipal Hospital Ganzhou China. Hauptthemen laut MEDLINE: I-kappa B Kinase, Myocytes, Cardiac, NF-kappa B, Cardiomegaly. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathological cardiac hypertrophy is a major risk factor for heart failure. NIBP (NF‐κB [nuclear factor kappa‐B] inducing kinase‐ and inhibitor of NF‐κB kinase subunit beta‐binding protein) is a key regulator of cytokine‐induced NF‐κB signaling, but its role in cardiac hypertrophy remains unknown.

Methods

We established transverse aortic constriction‐induced cardiac hypertrophy in mice and phenylephrine‐induced hypertrophy in neonatal rat ventricular myocytes. Genetic interventions included generation of whole‐body Nibp knockout mice via CRISPR‐Cas9; creation of cardiomyocyte‐specific Nibp knockout mice using adeno‐associated virus serotype 9‐delivered Cre and single‐guide RNAs in Rosa26‐LSL‐Cas9 mice; and cardiac‐specific Nibp overexpression via adeno‐associated virus serotype 9delivery. In neonatal rat ventricular myocytes, NIBP was knocked down or overexpressed using adenoviruses. Phenotypes were assessed by echocardiography, histology (wheat germ agglutinin, picrosirius redstaining), and molecular analyses. Mechanisms were investigated via RNA‐sequencing, coimmunoprecipitation, and Western blotting for key signaling molecules.

Results

NIBP protein was upregulated in hypertrophic hearts and cardiomyocytes. Both Nibp ‐knockout and cardiomyocyte‐specific Nibp knockout attenuated transverse aortic constriction‐induced cardiac dysfunction, hypertrophy, and fibrosis, whereas Nibp overexpression exacerbated these pathologies. Consistently, in neonatal rat ventricular myocytes, NIBP knockdown mitigated, while its overexpression aggravated, phenylephrine‐induced cardiomyocyte hypertrophy and inflammatory responses. Mechanistically, NIBP directly interacted with IKKβ (inhibitor of NF‐κB kinase subunit beta), enhanced its phosphorylation, and drove hyperactivation of the downstream NF‐κB pathway. Overexpression of a kinase‐dead IKKβ mutant reversed the hypertrophic effects of NIBP.

Conclusions

NIBP promotes pathological cardiac hypertrophy by activating the IKKβ/NF‐κB axis, identifying it as a potential therapeutic target for cardiac remodeling and heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

I-kappa B KinaseMyocytes, CardiacNF-kappa BCardiomegalyAnimalsMice, KnockoutDisease Models, AnimalSignal TransductionRatsMaleMiceRats, Sprague-DawleyFibrosisVentricular RemodelingCells, Cultured

Stichwörter der Autor:innen

IKKβNF‐κB signalingNIK‐ and IKKβ‐binding protein (NIBP)TAC surgerypathological cardiac hypertrophy

Substanzen

I-kappa B KinaseNF-kappa BIkbkb protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Guangdong Provincial People's Hospital Ganzhou Hospital Ganzhou Municipal Hospital Ganzhou China.
  • State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute Gannan Medical University Ganzhou China.
  • Department of Central Laboratory Renmin Hospital of Wuhan University Wuhan China.
  • Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) Southern Medical University Guangzhou China.

ORCID-Profile: Yingjie Zuo, Mengyao Wang, Xin Zhang, Hailong Yang, Zhonghan Ni, Hui Liu, Fang Pei

Zitieren

APA

Xie, Z., Zuo, Y., Wang, M., Zhang, X., Zhang, L., Liu, Z., Zhang, B., Su, Z., Yang, S., Yang, H., Zhang, J., Ni, Z., Liu, H., & Pei, F. (2026). Nuclear Factor Kappa‐B Inducing Kinase‐ and Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Binding Protein Promotes Pathological Cardiac Hypertrophy by Regulating Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Mediated Nuclear Factor Kappa‐B Activation. Journal of the American Heart Association, 15(21). https://doi.org/10.1161/jaha.125.046637

Vancouver

Xie Z, Zuo Y, Wang M, Zhang X, Zhang L, Liu Z, et al. Nuclear Factor Kappa‐B Inducing Kinase‐ and Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Binding Protein Promotes Pathological Cardiac Hypertrophy by Regulating Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Mediated Nuclear Factor Kappa‐B Activation. Journal of the American Heart Association. 2026;15(21). doi:10.1161/jaha.125.046637

BibTeX
@article{Xie2026,
  author = {Xie, Zheng and Zuo, Yingjie and Wang, Mengyao and Zhang, Xin and Zhang, Lirong and Liu, Zixuan and Zhang, Bilong and Su, Zhaohai and Yang, Saichao and Yang, Hailong and Zhang, Jianqing and Ni, Zhonghan and Liu, Hui and Pei, Fang},
  title = {Nuclear Factor Kappa‐B Inducing Kinase‐ and Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Binding Protein Promotes Pathological Cardiac Hypertrophy by Regulating Inhibitor of Nuclear Factor Kappa‐B Kinase Subunit Beta‐Mediated Nuclear Factor Kappa‐B Activation},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {21},
  doi = {10.1161/jaha.125.046637}
}
Kostenlos starten →